Current Clinical and Preclinical Photosensitizers for Use in Photodynamic Therapy
- 19 June 2004
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (16), 3897-3915
- https://doi.org/10.1021/jm040074b
Abstract
No abstract availableThis publication has 91 references indexed in Scilit:
- pH effects on the cellular uptake of four photosensitizing drugs evaluated for use in photodynamic therapy of cancerCancer Letters, 2003
- Experimental photodynamic therapy for malignant pleural mesothelioma with pegylatedmTHPCLasers in Surgery and Medicine, 2003
- An update on photodynamic therapy in age-related macular degenerationExpert Opinion on Pharmacotherapy, 2002
- Inverted meso-Aryl Porphyrins with Heteroatoms; Characterization of Thia, Selena, and Oxa N-Confused PorphyrinsThe Journal of Organic Chemistry, 2000
- Preferential photoinactivation of leukemia cells by aluminum phthalocyanineJournal of Photochemistry and Photobiology B: Biology, 1998
- 5,20-Diphenyl-10,15-bis(p-tolyl)-21-selenaporphyrin and Its Nickel(II) Complexes1Inorganic Chemistry, 1996
- Photodynamic Therapy of Gastrointestinal Tumors: A ReviewDigestive Diseases, 1992
- Photodynamic therapyEuropean Journal Of Cancer, 1992
- NEUROTOXICITY OF TETRAPHENYLPORPHINESULFONATE TPPS4 and ITS RELATION TO PHOTODYNAMIC THERAPY*Photochemistry and Photobiology, 1987
- Rhodamine 123 inhibits bioenergetic function in isolated rat liver mitochondriaBiochemical and Biophysical Research Communications, 1984